Fig. 2From: Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11–001AXAL planned phase III study. AXAL: axalimogene filolisbac; FIGO: International Federation of Gynecology and Obstetrics; GOG: Gynecologic Oncology Group; Q: quarter; UK: United Kingdom; US: United StatesBack to article page